Daxor Corporation (NASDAQ:DXR) — Market Cap & Net Worth
Market Cap & Net Worth: Daxor Corporation (DXR)
Daxor Corporation (NASDAQ:DXR) has a market capitalization of $60.84 Million ($60.84 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21113 globally and #4518 in its home market, demonstrating a 6.86% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Daxor Corporation's stock price $10.44 by its total outstanding shares 5827225 (5.83 Million). Analyse Daxor Corporation cash conversion from operations to see how efficiently the company converts income to cash.
Daxor Corporation Market Cap History: 2015 to 2026
Daxor Corporation's market capitalization history from 2015 to 2026. Data shows growth from $43.54 Million to $60.84 Million (1.74% CAGR).
Daxor Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Daxor Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
21.03x
Daxor Corporation's market cap is 21.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
83.55x
Daxor Corporation's market cap is 83.55 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $43.54 Million | $-7.44 Million | -$9.15 Million | -5.85x | N/A |
| 2016 | $47.39 Million | $1.84 Million | $1.46 Million | 25.82x | 32.55x |
| 2017 | $26.46 Million | $-1.01 Million | -$1.24 Million | -26.16x | N/A |
| 2018 | $47.78 Million | $-918.45K | -$885.77K | -52.03x | N/A |
| 2019 | $54.78 Million | $-114.99K | -$495.70K | -476.35x | N/A |
| 2020 | $72.84 Million | $-996.30K | -$1.71 Million | -73.11x | N/A |
| 2021 | $65.76 Million | $5.82 Million | $4.75 Million | 11.30x | 13.85x |
| 2022 | $53.38 Million | $6.31 Million | $5.18 Million | 8.46x | 10.31x |
| 2023 | $55.94 Million | $34.59 Million | $280.64K | 1.62x | 199.33x |
| 2024 | $44.81 Million | $2.13 Million | $536.33K | 21.03x | 83.55x |
Competitor Companies of DXR by Market Capitalization
Companies near Daxor Corporation in the global market cap rankings as of May 4, 2026.
Key companies related to Daxor Corporation by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #136 globally with a market cap of $162.57 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #250 globally with a market cap of $98.12 Billion USD ( €83.93 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #274 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #523 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #136 | Intuitive Surgical Inc | NASDAQ:ISRG | $162.57 Billion | $457.78 |
| #250 | EssilorLuxottica S. A. | PA:EL | $98.12 Billion | €181.25 |
| #274 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €88.50 |
| #523 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Daxor Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Daxor Corporation's market cap moved from $43.54 Million to $ 60.84 Million, with a yearly change of 1.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $60.84 Million | -29.22% |
| 2025 | $85.95 Million | +91.81% |
| 2024 | $44.81 Million | -19.90% |
| 2023 | $55.94 Million | +4.80% |
| 2022 | $53.38 Million | -18.83% |
| 2021 | $65.76 Million | -9.72% |
| 2020 | $72.84 Million | +32.98% |
| 2019 | $54.78 Million | +14.63% |
| 2018 | $47.78 Million | +80.59% |
| 2017 | $26.46 Million | -44.17% |
| 2016 | $47.39 Million | +8.84% |
| 2015 | $43.54 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Daxor Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $60.84 Million USD |
| MoneyControl | $60.84 Million USD |
| MarketWatch | $60.84 Million USD |
| marketcap.company | $60.84 Million USD |
| Reuters | $60.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more